LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.95 | 770.25 | 3943 | 4543 | 0.8678 | 0.8922 | MN20160304_L02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.95 | 770.25 | 4124 | 4543 | 0.9076 | 0.9257 | MN20160304_L02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.95 | 770.25 | 4012 | 4543 | 0.8830 | 0.9051 | MN20160304_L02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.95 | 770.25 | 4021 | 4543 | 0.8849 | 0.9068 | MN20160304_L02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.17 | 770.25 | 4346 | 5010 | 0.8674 | 0.8974 | MN20160304_L02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.17 | 770.25 | 4588 | 5010 | 0.9157 | 0.9358 | MN20160304_L02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.17 | 770.25 | 4461 | 5010 | 0.8903 | 0.9158 | MN20160304_L02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.17 | 770.25 | 4465 | 5010 | 0.8911 | 0.9164 | MN20160304_L02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.39 | 770.25 | 4793 | 5404 | 0.8869 | 0.9164 | MN20160304_L02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.39 | 770.25 | 4953 | 5404 | 0.9165 | 0.9389 | MN20160304_L02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.39 | 770.25 | 4741 | 5404 | 0.8773 | 0.9090 | MN20160304_L02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.39 | 770.25 | 4792 | 5404 | 0.8867 | 0.9162 | MN20160304_L02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.61 | 770.25 | 5118 | 5813 | 0.8804 | 0.9145 | MN20160304_L02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.61 | 770.25 | 5258 | 5813 | 0.9045 | 0.9323 | MN20160304_L02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.61 | 770.25 | 5144 | 5813 | 0.8849 | 0.9179 | MN20160304_L02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.61 | 770.25 | 5167 | 5813 | 0.8889 | 0.9208 | MN20160304_L02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.83 | 770.25 | 5492 | 6223 | 0.8825 | 0.9187 | MN20160304_L02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.83 | 770.25 | 5691 | 6223 | 0.9144 | 0.9415 | MN20160304_L02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.83 | 770.25 | 5586 | 6223 | 0.8976 | 0.9296 | MN20160304_L02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.83 | 770.25 | 5593 | 6223 | 0.8987 | 0.9304 | MN20160304_L02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.05 | 770.25 | 5910 | 6629 | 0.8915 | 0.9274 | MN20160304_L02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.05 | 770.25 | 6110 | 6629 | 0.9216 | 0.9481 | MN20160304_L02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.05 | 770.25 | 6127 | 6629 | 0.9242 | 0.9499 | MN20160304_L02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.05 | 770.25 | 6135 | 6629 | 0.9254 | 0.9507 | MN20160304_L02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 52.27 | 770.25 | 6215 | 7058 | 0.8805 | 0.9219 | MN20160304_L02 | D03 |